MedPath

SANDOZ PERINDOPRIL ERBUMINE

SANDOZ PERINDOPRIL ERBUMINE

Approved
DIN Number

02470225

Drug Class

Human

Market Date

Mar 5, 2018

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02470225
AIG Number0127178001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09AA04 PERINDOPRIL
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

PERINDOPRIL ERBUMINEActive
Strength: 2 MG
Monograph: PERINDOPRIL ERBUMINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.